Bausch + Lomb IPO vision more clear with new hire
This article was originally published in Clinica
Executive Summary
Despite strong signals at the JP Morgan Healthcare Conference in early January that an initial public offering was imminent for Bausch + Lomb, speculation about the eye care specialist's reentry to the public market remains rampant.